Tag: chronic limb threatening
LimFlow receives FDA approval for US study of minimally-invasive technology designed...
LimFlow has announced that the US Food and Drug Administration (FDA) has approved its investigational device exemption (IDE) for the PROMISE II pivotal study of...
